Medical · international-medical-cannabis-supply

Italy Plans to Double Military Cannabis Greenhouses by 2028

Rome's military pharmaceutical plant targets at least 700 kilograms of annual cannabis output by 2028, a step in Italy's state-run medical supply model.

By Tomas Greer, State Policy ReporterReviewed by Dr. Rosa Vargas, NDPublished November 22, 20264 min read
Detailed close-up shot of vibrant green cannabis leaves with selective focus, showing freshness and growth in a greenhouse environment.

Detailed close-up shot of vibrant green cannabis leaves with selective focus, showing freshness and growth in a greenhouse environment.

Italy plans to double its military-run cannabis greenhouses and produce at least 700 kilograms annually by 2028, according to a report from The Marijuana Herald. The expansion would scale the state's domestic medical supply and could reduce reliance on imported flower.

Italy targets 700 kilograms a year from expanded military greenhouses

Italy plans to double the greenhouse capacity used for state cannabis production and reach at least 700 kilograms of annual output by 2028, according to The Marijuana Herald.

The report, published Nov. 22, 2026, describes the plan as an expansion of the country's military-run production program. What CannIntel has in hand is a headline and summary, not the underlying government document. The specific ministerial act, budget line and implementation schedule behind the 2028 target couldn't be verified here.

CannIntel hasn't independently confirmed the 700-kilogram figure against an Italian defense or health ministry filing. Treat it as a reported target, not an enacted appropriation.

The program runs through the Italian armed forces' pharmaceutical plant

Italy's state cannabis supply is produced by the military, a structure that sets it apart from the licensed private-grower markets of Canada, Germany and most U.S. states.

Italy's medical cannabis framework dates to a 2007 ministerial decree that placed therapeutic use under the country's narcotics law, and the Ministry of Health later authorized the Stabilimento Chimico Farmaceutico Militare in Florence to cultivate cannabis for patients. That arrangement makes the state, not licensed commercial operators, the principal domestic producer. A capacity expansion is a procurement and public-health decision as much as an industrial one.

For operators, the structure matters. A government-run plant sets domestic volume by administrative decision, not by market entry, and that shapes how much room exists for importers and foreign licensed producers.

Why domestic scale matters for import-dependent supply

Italy has historically filled the gap between military output and patient demand with imported flower, so more domestic kilograms translate directly into fewer imports.

Italian pharmacies have relied on imports from the Netherlands and Canada to supplement the military's harvest, and shortages have periodically surfaced as demand grew. Doubling greenhouse capacity is a supply-side answer to that pattern.

Here's the arithmetic. Even if 700 kilograms is a floor and not a ceiling, it's a small volume against the multi-ton flows seen in larger European markets. Italy is building a patient-supply buffer, not an export engine.

Exporters in Canada, Portugal and elsewhere should note the distinction. Higher domestic output could trim import volumes at the margin, but a 700-kilogram target alone is unlikely to displace the bulk of foreign supply unless demand stays flat.

What is still unconfirmed, and what to watch

The decisive details remain unpublished in the material available: the funding source, the legal instrument, the construction timeline and the pricing mechanism.

Italian cannabis policy moves through ministerial decrees, interministerial agreements and parliamentary budget law, and each carries its own procedural path. A military production expansion would typically need a defense-health coordination step and a funded line item before greenhouses are built. None of those documents were included in the signal.

Watch for three things. First, a published decree or budget annex that fixes the 2028 output figure in law. Second, any change to the reimbursement or pricing rules that govern what the Ministry of Health pays for state-grown flower. Third, whether the plan carves out room for private licensed cultivation, which would change the structure of the market.

For full background on this story, see the CannIntel topic hub on Italy military cannabis production. Until a primary Italian government document surfaces, the 700-kilogram figure stays a reported target. That's the right way to carry it.

Frequently asked questions

How much cannabis does Italy plan to produce by 2028?

According to The Marijuana Herald, Italy plans to produce at least 700 kilograms annually by 2028 by doubling its military-run cannabis greenhouses. CannIntel has not verified the figure against a primary Italian government document.

Who produces medical cannabis in Italy?

The Italian armed forces' pharmaceutical plant in Florence, the Stabilimento Chimico Farmaceutico Militare, is the state's authorized domestic cannabis producer. Pharmacies have also relied on imports to supplement supply.

Will the expansion affect cannabis importers?

Possibly at the margin. More domestic output could reduce import volume, but 700 kilograms is small relative to larger European markets, so it is unlikely to displace foreign supply on its own.

Is the Italian expansion plan law yet?

That is not confirmed. The available report does not cite a decree, budget line or timeline. A funded ministerial or budget instrument would be needed to make the 2028 target binding.

Sources

Italy medical cannabismilitary cannabis productionEuropean cannabis supplyStabilimento Chimico Farmaceutico Militarecannabis imports
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Medical

More from the newsroom